Trial Profile
Efficacy and safety study of nabiximols for the treatment of spasticity in multiple sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- 18 Dec 2015 New trial record